Synergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study.

This retrospective study evaluated the impact of renin-angiotensin-aldosterone system inhibitors (RAASi) on outcomes in...

Continue ReadingSynergistic prognostic effect of the renin-angiotensin-aldosterone system and immune-checkpoint inhibition in advanced lung cancer: The SPERICIL study.